An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia

Ginkgo biloba extracts (GBEs) have been recommended to improve cognitive function and to prevent cognitive decline, but earlier evidence was inconclusive. Here, we evaluated all systematic reviews of GBEs for prevention of cognitive decline, and intervention of mild cognitive impairment (MCI) and de...

Full description

Bibliographic Details
Main Authors: Guo-qing Zheng, Hong-feng Zhang, Li-bo Huang, Yan-biao Zhong, Qi-hui Zhou, Hui-lin Wang, Yan Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnagi.2016.00276/full
id doaj-8ab86b3218824ed29ebd11cddc043ece
record_format Article
spelling doaj-8ab86b3218824ed29ebd11cddc043ece2020-11-24T23:53:28ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652016-12-01810.3389/fnagi.2016.00276205939An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementiaGuo-qing Zheng0Hong-feng Zhang1Li-bo Huang2Yan-biao Zhong3Qi-hui Zhou4Hui-lin Wang5Yan Lin6The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityThe Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityThe Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityThe Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityThe Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityThe Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityThe Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityGinkgo biloba extracts (GBEs) have been recommended to improve cognitive function and to prevent cognitive decline, but earlier evidence was inconclusive. Here, we evaluated all systematic reviews of GBEs for prevention of cognitive decline, and intervention of mild cognitive impairment (MCI) and dementia. Six databases from their inception to September 2015 were searched. Ten systematic reviews were identified, including reviews about Alzheimer’s disease (n=3), about vascular dementia (n=1), about both Alzheimer’s disease and vascular dementia (n=2), about Alzheimer’s disease, vascular dementia and mixed dementia (n=3), and a review about MCI (n=1). Based on the overview quality assessment questionnaire, eight studies were scored with at least 5 points, while the other two scored 4 points and 3 points, respectively. Medication with GBEs showed improvement in cognition, neuropsychiatric symptoms, and daily activities, and the effect was dose-dependent. Efficacy was convincingly demonstrated only when high daily dose (240mg) was applied. Compared with placebo, overall adverse events and serious adverse events were at the same level as placebo, with less adverse events in favor of GBE in the subgroup of Alzheimer's disease patients, and fewer incidences in vertigo, tinnitus, angina pectoris, and headache. In conclusion, there is clear evidence to support the efficacy of GBEs for MCI and dementia, whereas the question on efficacy to prevent cognitive decline is still open. In addition, GBEs seem to be generally safe.http://journal.frontiersin.org/Journal/10.3389/fnagi.2016.00276/fullDementiaGinkgo bilobaMild Cognitive ImpairmentAlzheimer’s diseaseVascular Dementia
collection DOAJ
language English
format Article
sources DOAJ
author Guo-qing Zheng
Hong-feng Zhang
Li-bo Huang
Yan-biao Zhong
Qi-hui Zhou
Hui-lin Wang
Yan Lin
spellingShingle Guo-qing Zheng
Hong-feng Zhang
Li-bo Huang
Yan-biao Zhong
Qi-hui Zhou
Hui-lin Wang
Yan Lin
An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
Frontiers in Aging Neuroscience
Dementia
Ginkgo biloba
Mild Cognitive Impairment
Alzheimer’s disease
Vascular Dementia
author_facet Guo-qing Zheng
Hong-feng Zhang
Li-bo Huang
Yan-biao Zhong
Qi-hui Zhou
Hui-lin Wang
Yan Lin
author_sort Guo-qing Zheng
title An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
title_short An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
title_full An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
title_fullStr An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
title_full_unstemmed An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
title_sort overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2016-12-01
description Ginkgo biloba extracts (GBEs) have been recommended to improve cognitive function and to prevent cognitive decline, but earlier evidence was inconclusive. Here, we evaluated all systematic reviews of GBEs for prevention of cognitive decline, and intervention of mild cognitive impairment (MCI) and dementia. Six databases from their inception to September 2015 were searched. Ten systematic reviews were identified, including reviews about Alzheimer’s disease (n=3), about vascular dementia (n=1), about both Alzheimer’s disease and vascular dementia (n=2), about Alzheimer’s disease, vascular dementia and mixed dementia (n=3), and a review about MCI (n=1). Based on the overview quality assessment questionnaire, eight studies were scored with at least 5 points, while the other two scored 4 points and 3 points, respectively. Medication with GBEs showed improvement in cognition, neuropsychiatric symptoms, and daily activities, and the effect was dose-dependent. Efficacy was convincingly demonstrated only when high daily dose (240mg) was applied. Compared with placebo, overall adverse events and serious adverse events were at the same level as placebo, with less adverse events in favor of GBE in the subgroup of Alzheimer's disease patients, and fewer incidences in vertigo, tinnitus, angina pectoris, and headache. In conclusion, there is clear evidence to support the efficacy of GBEs for MCI and dementia, whereas the question on efficacy to prevent cognitive decline is still open. In addition, GBEs seem to be generally safe.
topic Dementia
Ginkgo biloba
Mild Cognitive Impairment
Alzheimer’s disease
Vascular Dementia
url http://journal.frontiersin.org/Journal/10.3389/fnagi.2016.00276/full
work_keys_str_mv AT guoqingzheng anoverviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT hongfengzhang anoverviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT libohuang anoverviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT yanbiaozhong anoverviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT qihuizhou anoverviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT huilinwang anoverviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT yanlin anoverviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT guoqingzheng overviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT hongfengzhang overviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT libohuang overviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT yanbiaozhong overviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT qihuizhou overviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT huilinwang overviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
AT yanlin overviewofsystematicreviewsofginkgobilobaanditsextractsformildcognitiveimpairmentanddementia
_version_ 1725469498144718848